Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
De Smedt
Ann
A
Department of Neurology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Brussels, Belgium.
De Raedt
Sylvie
S
Nieboer
Koenraad
K
De Keyser
Jacques
J
Brouns
Raf
R
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D002533:Cerebral Angiography; D000069604:Dabigatran; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D020521:Stroke / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D015091:beta-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D011994:Recombinant Proteins; D015091:beta-Alanine; D010959:Tissue Plasminogen Activator; D000069604:Dabigatran